By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 24 August 2023 A new study from the universities of Lund and Gothenburg, among others, provides knowledge that can be used in individual risk assessment, preventive measures and treatment strategies for breast cancer patients. Photo: Foto: iStock/Rasi Bhadramani BRCA1 and BRCA2 are well-known breast cancer genes associ

https://www.medicine.lu.se/article/breast-cancer-study-altered-guidelines-sweden - 2025-01-11

By anna [dot] hellgren [at] med [dot] lu [dot] se (Anna Hellgren) - published 18 September 2023 Esther González-Padilla and Markus Heidenblad, photo: Ingemar Hultquist On September 28, the official launch of SciLifeLab Lund will take place in Forum Medicum. Lund is one of the four new sites that were established in 2022. The sites in Gothenburg, Linköping, Umeå and Lund are part of a major govern

https://www.medicine.lu.se/article/kick-scilifelab-lund - 2025-01-11

By katrin [dot] stahl [at] med [dot] lu [dot] se (Katrin Ståhl) - published 19 September 2023 Photo: iStock/Gab13. Is it possible that a single biomarker can detect all types of diseases related to dopamine deficiency in the brain? Yes, that's what a research group in Lund is discovering. "We have observed that an enzyme in cerebrospinal fluid and in blood is a useful marker for identifying all ty

https://www.medicine.lu.se/article/new-blood-marker-can-identify-parkinsonian-diseases-0 - 2025-01-11

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 29 September 2023 Using a data-driven, bioinformatics approach, Lund University researchers have made it possible to take a holistic approach to how our blood group genes are regulated. Photo: iStock/choja Currently, a lot is known about which genes are responsible for our individual blood groups, however not much is understoo

https://www.medicine.lu.se/article/new-bioinfomatics-pipeline-solves-50-year-old-blood-group-puzzle - 2025-01-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 5 October 2023 Using precision medicine in diabetes means that treatment of the disease and its complications can become more precise and accurate. Photo: iStock An international consensus report on diabetes identifies the potential for diabetes screening, better classification of type 2 diabetes, and biomarkers that can p

https://www.medicine.lu.se/article/new-report-opportunities-and-challenges-precision-diabetes-medicine - 2025-01-11

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 11 October 2023 The researchers behind the study on pressure-induced vascular damage, from left: Johan Holmberg, Olivia Ritsvall, Karl Swärd, Marycarmen Arévalo-Martinez and Sebastian Albinsson. Photo: Åsa Hansdotter. A research group at Lund University has studied how a molecular sensor located in the blood vessel wal

https://www.medicine.lu.se/article/how-your-blood-vessels-tolerate-high-blood-pressure - 2025-01-11

Published 13 October 2023 By reprogramming tumor cells into the body's defense cells, Filipe Pereira and his colleagues aim to improve cancer treatments. Foto: Tove Smeds Filipe Pereira, professor of molecular medicine at Lund University, is awarded this year's Fernström prize for young, exceptionally promising, and successful researchers. He receives the award for his work on reprogramming blood

https://www.medicine.lu.se/article/filipe-pereira-awarded-eric-k-fernstrom-prize-young-researchers - 2025-01-11

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 18 October 2023 Filipe Pereira (R) coordinates the research project which is allocated 33 million from the EIC. Together with Fábio Fiúza Rosa (L), he is also one of the founders of the company Asgard Therapeutics, partner in the EIC project. Photo: Asgard Therapeutics An international research project led from Lund Un

https://www.medicine.lu.se/article/enemy-friend-33-million-reprogramming-cancer-cells - 2025-01-11

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 19 October 2023 Cancer researcher Harald Stenmark, professor at the University of Oslo and Oslo University Hospital, is the recipient of Eric K. Fernström Nordic Prize 2023. Photo: Øystein Horgmo. Cancer researcher Harald Stenmark, professor at the University of Oslo and Oslo University Hospital, is the recipient of this year’

https://www.medicine.lu.se/article/eric-k-fernstrom-nordic-prize-2023-awarded-cancer-researcher - 2025-01-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 6 November 2023 Diabetes researcher Rashmi Prasad at Lund University has been awarded this year's Medeon Scholarship for her research on the inheritance of type 2 diabetes and why the disease is inherited from the mother to a greater extent. Photo: Petra Olsson. How do heritability and the fetal environment affect the risk

https://www.medicine.lu.se/article/research-inherited-type-2-diabetes-awarded - 2025-01-11

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 7 November 2023 Tony Ingesson and David Gisselsson Nord. Photo: Åsa Hansdotter David Gisselsson Nord and Tony Ingesson both love spy novels and have a nerdy interest in history. Their shared curiosity resulted in an interdisciplinary collaboration about how it might be possible to inspire smarter cancer treatment with

https://www.medicine.lu.se/article/cancer-researcher-and-intelligence-expert - 2025-01-11

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 24 November 2023 Image: iStock/Zanuck Breath-holding spells are common in young children and are benign. Yet children often undergo unnecessary diagnostic interventions when seeking medical care. This is because there are no national or international guidelines on how to assess children in these cases. A team of resear

https://www.medicine.lu.se/article/children-breath-holding-spells-undergo-unnecessary-diagnostic-interventions - 2025-01-11

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 30 November 2023 Image: iStock. Researchers have succeeded in restoring lost brain function in mouse models of stroke using small molecules that in the future could potentially be developed into a stroke therapy. “Communication between nerve cells in large parts of the brain changes after a stroke and we show that it can be pa

https://www.medicine.lu.se/article/new-study-lost-brain-function-restored-after-stroke - 2025-01-11

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 5 December 2023 Spinocerebellar ataxias, SCA diseases, are a large group of rare, hereditary diseases in which difficulties in coordinating movements are common. Researchers have now solved the mystery behind one of SCA's diseases. Image: iStock/Andriy Yalanskyi. Intensive efforts are being made in medical research to

https://www.medicine.lu.se/article/researchers-have-found-genetic-cause-type-hereditary-ataxia-sca4-long-unresolved-conundrum - 2025-01-11

By alexis [dot] bento_luis [at] med [dot] lu [dot] se (Alexis Bento Luis) - published 18 December 2023 Christopher Douse explores the repetitive portion of the human genome, so-called ‘genomic dark matter’, and its role in human brain development and degeneration. Photo: Alexis Bento Luis. Christopher Douse, a new group leader at the Faculty of Medicine at Lund University, has been awarded the Ben

https://www.medicine.lu.se/article/exploring-genomic-dark-matter-christopher-douse-awarded-12m-grant-chan-zuckerberg-initiative - 2025-01-11

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 18 December 2023 The cerebellum plays an important role in motor skills and timing. Researchers link the changes found in the cerebellum in ADHD to a finger-tapping test. Photo: iStock. Through a simple, inexpensive five-minute test, one can obtain an initial indication of whether a child has ADHD or not. This is demon

https://www.medicine.lu.se/article/five-minute-test-indicate-adhd - 2025-01-11

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 10 January 2024 Ganna Petruk and Artur Schmidtchen, two of the reserchers behind the study of a new treatment strategy for severe bacterial infections. Photo: Tove Smeds. The development of a new treatment strategy for bacterial infections and sepsis is being led by researchers at Lund University. In a study the researchers de

https://www.medicine.lu.se/article/step-closer-treatment-severe-bacterial-infections-and-sepsis - 2025-01-11

By press [at] med [dot] lu [dot] se (Faculty of Medicine) - published 26 January 2024 Out of the 195 biomarkers examined, 13 were significantly associated with cardiovascular risk in people with type 2 diabetes. Photograph: iStock An international team of researchers has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with

https://www.medicine.lu.se/article/new-study-biomarkers-improve-prediction-cardiovascular-disease-type-2-diabetes-2 - 2025-01-11

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 7 February 2024 The picture shows how a drug (orange) attaches to the aquaporin (purple), resulting in the aquaporin no longer being able to transport molecules across the cell membrane. Photo: Raminta Venskutonyte. Aquaporins are proteins that regulate the flow of water in and out of cells. These proteins have been fo

https://www.medicine.lu.se/article/blocks-aquaporins-thereby-inhibiting-cancer-growth - 2025-01-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 15 February 2024 Anna Blom and Ben C King have discovered that C3 protein protects insulin-producing cells. Photo: Rebecca Rosberg Much research on diabetes focuses on understanding what happens when the insulin-producing cells are destroyed. Researchers at Lund University have instead chosen to investigate what protects t

https://www.medicine.lu.se/article/protein-protects-insulin-producing-cells - 2025-01-11